UID:
almahu_9949725366402882
Umfang:
VIII, 368 p. 33 illus., 28 illus. in color.
,
online resource.
Ausgabe:
1st ed. 2023.
ISBN:
9783031336027
Serie:
Cancer Treatment and Research, 188
Inhalt:
This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters. Breast cancer is still the most common cancer and cause of cancer deaths among women worldwide. The improvement of breast cancer outcome appears to be strictly related to the validation of precise biomarkers that enable us to better select personalized approaches in breast cancer management. The closing chapters deal with the challenges of low income countries of conducting research in the era of precision medicine forcancer. The book is edited and authored by leading experts in this field and will be of interest for clinicians and scientists alike.
Anmerkung:
Antibody-drug conjugates -- Tumor-Infiltrating Lymphocytes as a Surrogate Biomarker for PD-L1 -- Immune checkpoint inhibitors -- Screening programs for breast cancer -- Transversal perspectives of integrative oncology care -- Assessment and response to neoadjuvant treatments -- Precision surgery for the treatment of breast cancer -- A precise approach for radiation therapy of breast cancer -- Fast mimicking diets and other innovative nutritional interventions to treat patients with breast cancer -- Endocrine resistance of breast cancer -- Innovative therapeutic approaches for patients with HER2- positive breast cancer -- Management of patients with breast cancer and brain metastasis -- New concepts in cardio-oncology -- Clinical utility, cost-effectiveness, and budgetary impact of next-generation sequencing in metastatic breast cancer -- ONCOLLEGE-001: The global landscape on the access to cancer medicines for breast cancer.
In:
Springer Nature eBook
Weitere Ausg.:
Printed edition: ISBN 9783031336010
Weitere Ausg.:
Printed edition: ISBN 9783031336034
Weitere Ausg.:
Printed edition: ISBN 9783031336041
Sprache:
Englisch
DOI:
10.1007/978-3-031-33602-7
URL:
https://doi.org/10.1007/978-3-031-33602-7
Bookmarklink
